These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21996280)

  • 1. New advances in NMDA receptor pharmacology.
    Ogden KK; Traynelis SF
    Trends Pharmacol Sci; 2011 Dec; 32(12):726-33. PubMed ID: 21996280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor GluN2B-selective Antagonists.
    Stroebel D; Buhl DL; Knafels JD; Chanda PK; Green M; Sciabola S; Mony L; Paoletti P; Pandit J
    Mol Pharmacol; 2016 May; 89(5):541-51. PubMed ID: 26912815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel family of negative and positive allosteric modulators of NMDA receptors.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of Triheteromeric
    Yi F; Zachariassen LG; Dorsett KN; Hansen KB
    Mol Pharmacol; 2018 May; 93(5):453-467. PubMed ID: 29483146
    [No Abstract]   [Full Text] [Related]  

  • 5. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
    Zhu Z; Yi F; Epplin MP; Liu D; Summer SL; Mizu R; Shaulsky G; XiangWei W; Tang W; Burger PB; Menaldino DS; Myers SJ; Liotta DC; Hansen KB; Yuan H; Traynelis SF
    Neuropharmacology; 2020 Oct; 176():108117. PubMed ID: 32389749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of NMDA receptors and the mechanism of inhibition by ifenprodil.
    Tajima N; Karakas E; Grant T; Simorowski N; Diaz-Avalos R; Grigorieff N; Furukawa H
    Nature; 2016 Jun; 534(7605):63-8. PubMed ID: 27135925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors.
    Karakas E; Simorowski N; Furukawa H
    Nature; 2011 Jun; 475(7355):249-53. PubMed ID: 21677647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel allosteric modulator binding sites in NMDA receptors: A molecular modeling study.
    Kane LT; Costa BM
    J Mol Graph Model; 2015 Sep; 61():204-13. PubMed ID: 26280688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis of Functional Transitions in Mammalian NMDA Receptors.
    Chou TH; Tajima N; Romero-Hernandez A; Furukawa H
    Cell; 2020 Jul; 182(2):357-371.e13. PubMed ID: 32610085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse modes of NMDA receptor positive allosteric modulation: Mechanisms and consequences.
    Hackos DH; Hanson JE
    Neuropharmacology; 2017 Jan; 112(Pt A):34-45. PubMed ID: 27484578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptor subunits: function and pharmacology.
    Paoletti P; Neyton J
    Curr Opin Pharmacol; 2007 Feb; 7(1):39-47. PubMed ID: 17088105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.
    Ritter N; Korff M; Markus A; Schepmann D; Seebohm G; Schreiber JA; Wünsch B
    Cell Physiol Biochem; 2021 Mar; 55(S3):1-13. PubMed ID: 33656308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subunit assembly of N-methyl-d-aspartate receptors analyzed by fluorescence resonance energy transfer.
    Qiu S; Hua YL; Yang F; Chen YZ; Luo JH
    J Biol Chem; 2005 Jul; 280(26):24923-30. PubMed ID: 15888440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of NMDA receptor functional diversity.
    Paoletti P
    Eur J Neurosci; 2011 Apr; 33(8):1351-65. PubMed ID: 21395862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in allosteric modulators for GluN2A subunit and development of GluN2A-selective nuclear imaging probes.
    He Y; Mu L; Ametamey SM; Schibli R
    J Labelled Comp Radiopharm; 2019 Jun; 62(8):552-560. PubMed ID: 31037756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.
    Hansen KB; Traynelis SF
    J Neurosci; 2011 Mar; 31(10):3650-61. PubMed ID: 21389220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-guided design of new indoles as negative allosteric modulators (NAMs) of N-methyl-D-aspartate receptor (NMDAR) containing GluN2B subunit.
    Buemi MR; De Luca L; Ferro S; Russo E; De Sarro G; Gitto R
    Bioorg Med Chem; 2016 Apr; 24(7):1513-9. PubMed ID: 26912202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulators of NMDA receptors: multiple sites and mechanisms.
    Zhu S; Paoletti P
    Curr Opin Pharmacol; 2015 Feb; 20():14-23. PubMed ID: 25462287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GluN2B subunit represents a major functional determinant of NMDA receptors in human induced pluripotent stem cell-derived cortical neurons.
    Neagoe I; Liu C; Stumpf A; Lu Y; He D; Francis R; Chen J; Reynen P; Alaoui-Ismaili MH; Fukui H
    Stem Cell Res; 2018 Apr; 28():105-114. PubMed ID: 29454156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.